These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 19485753

  • 1. Expanding prevention of invasive meningococcal disease.
    Pelton SI, Gilmet GP.
    Expert Rev Vaccines; 2009 Jun; 8(6):717-27. PubMed ID: 19485753
    [Abstract] [Full Text] [Related]

  • 2. Quadrivalent meningococcal conjugate vaccines.
    Pace D, Pollard AJ, Messonier NE.
    Vaccine; 2009 Jun 24; 27 Suppl 2():B30-41. PubMed ID: 19477560
    [Abstract] [Full Text] [Related]

  • 3. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.
    Pace D.
    Expert Rev Vaccines; 2009 May 24; 8(5):529-42. PubMed ID: 19397410
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
    McVernon J, Nolan T, Richmond P, Reynolds G, Nissen M, Lambert SB, Marshall H, Papa T, Rehm C.
    Pediatr Infect Dis J; 2012 Jan 24; 31(1):e15-23. PubMed ID: 22094636
    [Abstract] [Full Text] [Related]

  • 5. Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006.
    Kinlin LM, Jamieson F, Brown EM, Brown S, Rawte P, Dolman S, Drews SJ, Fisman DN.
    Vaccine; 2009 Mar 10; 27(11):1735-40. PubMed ID: 19186206
    [Abstract] [Full Text] [Related]

  • 6. Meningococcal C vaccines: the Canadian experience.
    De Wals P.
    Pediatr Infect Dis J; 2004 Dec 10; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of meningococcal serogroup C vaccine programmes.
    Borrow R, Abad R, Trotter C, van der Klis FR, Vazquez JA.
    Vaccine; 2013 Sep 23; 31(41):4477-86. PubMed ID: 23933336
    [Abstract] [Full Text] [Related]

  • 8. Meningococcal C conjugate vaccine: the experience in England and Wales.
    Campbell H, Borrow R, Salisbury D, Miller E.
    Vaccine; 2009 Jun 24; 27 Suppl 2():B20-9. PubMed ID: 19477053
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
    Ceyhan M, Yildirim I, Balmer P, Riley C, Laher G, Andrews N, Borrow R, Kurt N, Turgut M, Aydogan A, Ecevit C, Uysal G, Schultze V.
    Vaccine; 2007 Oct 10; 25(41):7233-7. PubMed ID: 17707957
    [Abstract] [Full Text] [Related]

  • 11. Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model.
    Trotter CL, Edmunds WJ.
    Med Decis Making; 2006 Oct 10; 26(1):38-47. PubMed ID: 16495199
    [Abstract] [Full Text] [Related]

  • 12. Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy.
    Pezzotti P, Miglietta A, Neri A, Fazio C, Vacca P, Voller F, Rezza G, Stefanelli P.
    Vaccine; 2018 Jul 05; 36(29):4222-4227. PubMed ID: 29895504
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
    Cohen R, Levy C.
    Arch Pediatr; 2012 Sep 05; 19 Suppl 2():S61-4. PubMed ID: 22883368
    [Abstract] [Full Text] [Related]

  • 15. Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region.
    Soriano-Gabarró M, Wolter J, Hogea C, Vyse A.
    Expert Rev Anti Infect Ther; 2011 Sep 05; 9(9):761-74. PubMed ID: 21905785
    [Abstract] [Full Text] [Related]

  • 16. Meningococcal group A, C, Y and W-135 conjugate vaccine.
    Harrison LH, Mohan N, Kirkpatrick P.
    Nat Rev Drug Discov; 2010 Jun 05; 9(6):429-30. PubMed ID: 20514064
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An Update on Meningococcal Vaccination.
    Garland JM.
    R I Med J (2013); 2020 Aug 03; 103(6):41-43. PubMed ID: 32752565
    [Abstract] [Full Text] [Related]

  • 19. Serogroup C meningococcal conjugate vaccines: new preparations. Effective from age two months.
    Prescrire Int; 2003 Apr 03; 12(64):43-6. PubMed ID: 12675020
    [Abstract] [Full Text] [Related]

  • 20. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
    Mueller JE, Borrow R, Gessner BD.
    Expert Rev Vaccines; 2006 Jun 03; 5(3):319-36. PubMed ID: 16827617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.